New research presented by Stephen Rose, M.D., chief medical officer of Solis Mammography and president of Rose Imaging Physicians Group, Houston, at the 2016 Radiological Society of North America (RSNA) annual meeting found recall rates, cancer detection and invasive cancer detection for women under age 50 were significantly improved with the addition of digital breast tomosynthesis (DBT) to mammography.1

Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in recent years as noninvasive cancer therapy that does not require radiation, chemotherapy or surgery, resulting in less collateral damage to the patient. FUS is performed as an outpatient procedure, so it can eliminate the usual two weeks of recovery needed from most types of surgery.

The emerging markets of Asia-Pacific and Latin America will drive the medical imaging market by more than 5 percent by 2021. Globally, medical imaging has transformed the methods of diagnostics and has made the diagnosis and treatment of several medical conditions more effective and efficient in the modern era. Growing awareness about the usage of imaging devices for treatment in the healthcare segment and advancements in technologies is driving the global market for medical imaging worldwide.

With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report from market research firm GlobalData.